Plasma growth hormone secretion during constant growth hormone-releasing factor infusion.
- 1 January 1984
- journal article
- research article
- Published by Japan Endocrine Society in Endocrinologia Japonica
- Vol. 31 (6) , 681-685
- https://doi.org/10.1507/endocrj1954.31.681
Abstract
Synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) was infused i.v., at a constant rate of 2.5 .mu.g/min for 180 min in 3 normal boys of short stature. Plasma GH [growth hormone] levels reached a peak at 60-120 min with a mean value (.+-. SEM [standard error of the mean]) of 69.1 .+-. 14.3 ng/ml, and then, declined gradually in spite of continuous hpGRF-44 infusion up to 180 min. Similarly, constant infusion of hpGRF-44 at a rate of 2.5 .mu.g/min in 5 normal but short boys for 90 min, together with an i.v., bolus injection of hpGRF-44 (2 .mu.g/kg) administered at 0 and 90 min, elicited a prompt rise in plasma GH 15-30 minutes after the 1st bolus but no significant elevation of GH was observed after the 2nd bolus. When 2 i.v., bolus injections of hpGRF-44 (2 .mu.g/kg) were given in 4 normal boys with short stature at 0 and 90 min, respectively, significant elevation of plasma GH was found after each bolus. Apparently, under constant infusion of GRF the pituitary experiences a down-regulation after the initial peak of GH response, possibly due to desensitization to GRF.This publication has 9 references indexed in Scilit:
- Plasma Growth Hormone (GH) Response to GH-Releasing Factor in Normal Children with Short Stature and Patients with Pituitary Dwarfism*Journal of Clinical Endocrinology & Metabolism, 1984
- EFFECTS OF HUMAN PANCREATIC TUMOUR GROWTH HORMONE RELEASING FACTOR ON GROWTH HORMONE AND SOMATOMEDIN C LEVELS IN PATIENTS WITH IDIOPATHIC GROWTH HORMONE DEFICIENCYThe Lancet, 1983
- HUMAN PANCREATIC GROWTH-HORMONE-RELEASING FACTOR SELECTIVELY STIMULATES GROWTH-HORMONE SECRETION IN MANThe Lancet, 1983
- Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused AcromegalyScience, 1982
- characterization of A 40 residue peptide from a human pancreatic tumor with growth hormone releasing activityBiochemical and Biophysical Research Communications, 1982
- Down-Regulation of Pituitary Gonadotropin Secretion in Postmenopausal Females by Continuous Gonadotropin-Releasing Hormone Administration*Journal of Clinical Endocrinology & Metabolism, 1981
- Pituitary and Gonadal Desensitization after Continuous Luteinizing Hormone-Releasing Hormone Infusion in Normal Females*Journal of Clinical Endocrinology & Metabolism, 1980
- Induction of Immunoreactive Somatomedin C in Human Serum by Growth Hormone: Dose-Response Relationships and Effect on Chromatographic Profiles*Journal of Clinical Endocrinology & Metabolism, 1980
- Pituitary-Thyroid Responses to 4-Hour Constant Infusions of Thyrotropin Releasing Hormone in ManJournal of Clinical Endocrinology & Metabolism, 1977